Peri-operative and Post-operative Management of Hemophiliac Patients with Inhibitors
In the past, elective orthopedic surgery in hemophilic patients with inhibitors was usually not contemplated because of the high risk of bleeding complications. Thanks to the progress made in the development of bypassing therapies, elective surgery has become feasible; however, only centers that are already experienced can tackle this challenge. A strict collaboration amongst surgeons, hematologists, and physiotherapists is essential for a successful long-term outcome.
KeywordsRecombinant Factor VIIa Inhibitor Titer Factor VIII Inhibitor Immune Tolerance Induction Elective Orthopedic Surgery
Unable to display preview. Download preview PDF.
- 12.Ludlam CA, Smith MP, Morfini M et al (2003) A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation. Br J Haematol 120:808–813PubMedCrossRefGoogle Scholar